Mathew Martoma is an American former hedge fund trader. As a portfolio manager at S.A.C. ... to sell shares of pharmaceutical companies Wyeth and Elan Corporation based on tips from two doctors, including Sid Gilman of the University of Michigan, about the Alzheimer's disease drug bapineuzumab during clinical trials ...
Wyeth v. Levine (2009) established that such claims may go forward—in other words, they are ...... Strayhorn panel, Judge Gillman observed that the court felt.
I was privileged to work with Betsy for 11 years, both as Wyeth and Pfizer colleagues. Betsy is a strategic thinker, always looking for opportunity to improve ...
He has served as a consultant for Wyeth, ReNeuron, Adamas, and Kyowa and has grant support from ... Address correspondence and reprint requests to Dr. Sid Gilman, Department of Neurology, ... Colosimo C, Vanacore N, Bonifati V, et al.
Dr. Steven C. Gilman, also known as Steve, Ph.D., is Scientific Advisor of Spero Therapeutics, Inc. Dr. Gilman has been the Chief Executive Officer and President ...
Oct 13, 2014 ... But in recent years two pharmaceutical companies, Elan and Wyeth, had worked ... By the time Gilman made his presentation, however, S.A.C. Capital no longer owned ...... Martoma was there, wearing a neat V-neck sweater.
Howard Gillman, Mark A. Graber, and Keith E. Whittington. INDEX OF ... Kamper v. Hawkins ii. Hayburn's Case iii. Vanhorne's Lessee v. Dorrance iv. ..... Granholm v. Heald iv. Wyeth v. Levine v. South Central Bell Telephone Co. v. Alabama vi.
Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 12e ...... of the U.S. added further fuel to these fiery issues in 2009 in the case Wyeth v.
Smith v. Wyeth, Inc., 657 F.3d 420 (6th Cir. Sept. 22, 2011) (metoclopramide). State law ...... Gillman v. Boston Scientific Corp., 2012 WL 892239 (Mag. D. Or. Jan.